A seeming conundrum regarding the ability of some leukemic cells (i.e. CLL) to sequester ascorbate (ASC) has led to confusion regarding the safety and utility of high dose ascorbate delivered via IV (HDIVC). This has led to some apparent confusion between this concern and the apparent positive benefits of HDIVC seen in clinical practice.
6B – Leukemia and Oxidative Therapies Including Intravenous Ascorbic Acid / HDIVC
More IV Monographs
GlutathioneUse in cell repair and augmentation of parenteral glutathione before and after administration:Rationale and formula developed for the BIORC –
Rationale and formula developed for the BIORC – AMSA Clinics during the integrative oncology study.